By Kevin Robillard (Politico) –
GOP Sen. Marco Rubio will face Democratic Rep. Patrick Murphy after both won their Senate primaries in Florida Tuesday night.read more
Plant Vogtle’s Units 3 and 4, the first new nuclear units built in the United States in the past thirty years(!) are continuing on in their construction, with the two massive cooling towers nearly finished and the nuclear islands and turbine buildings still going up.
By Hastings Wyman –
In an effort to broaden his appeal to include more support from the African-American community, Donald Trump made a high-profile call for bringing more jobs and more cops to black neighborhoods. However, he painted his hoped-for-supporters with a broad brush. “You’re living in poverty. Your schools are no good. You have no jobs… What the hell do you have to lose?” While he may have meant just the inner-city ghettos, he didn’t say that, at least at first, and his appeal has stirred more – not less – opposition to Trump among African Americans.
By SPR Staff –
When Congress last December passed the Every Student Succeeds Act– ESSA– it effectively returned significant power back to the states in the field of education. It replaces the No Child Left Behind law, which had been under increasing criticism in recent years from both the political Right and Left. ESSA now allows states and local schools/districts to make more education decisions and requires states to develop plans that address standards/assessments, school and district accountability, as well as assistance for struggling schools and students.
By Nick Gass (Politico) –
Hillary Clinton has blown open a 16-point lead over Donald Trump in Virginia, according to the results of the latest Roanoke College poll of likely voters in the battleground state out Tuesday.
By U.S. Rep. Buddy Carter (R-Georgia) –
The Center for Medicare and Medicaid Innovation (CMMI) within the Centers for Medicare and Medicaid Services (CMS) has proposed a dangerous experiment with Part B drug payments. Under the experiment, Medicare payments would be significantly below a physician’s acquisition costs for a drug. This will put patients at risk by potentially forcing them to abandon the best treatments for a cheaper, less effective alternative. Millions of Medicare patients depend on access to lifesaving treatments and this experiment will not only result in negative consequences for treatment, it is also the first step to government price controls.
Editor and Publisher:
Chief Operating Officer/Staff Writer:
Circulation Director/ Staff Writer:
Advertising & Sales:
P.O. Box 724787
Atlanta, GA 31139
Phone: (404) 233-3710